Showing posts with label Gastroenterology. Show all posts
Showing posts with label Gastroenterology. Show all posts

26 November 2016

Ulcerative colitis ppts and latest publications

Ulcerative colitis

Inflammatory Bowel Disease Ulcerative Colitis, Crohn’s 
Chetan Irwin

Rectal Bleeding
Jessica Cintolo, Scott Q. Nguyen, M.D., Celia Divino, M.D.

Review of Inflammatory Bowel Disease Crohn Disease, Ulcerative Colitis, Pseudomembranous Colitis

Update on the Medical Treatment of Crohn’s Disease
Dahlia Awais, MD, MS

Correlation Between Bacteria and Inflammatory Bowel Diseases
Scott Belozer

Approach To The Patient with Chronic Diarrhea
Eric M. Osgard MD FACG

Cutaneous Manifestations of Systemic Disease
Holly Edmonds, MD

Medical Nutrition Therapy for Disorders of the Lower Gastrointestinal Tract

Nursing Care of Clients with Upper Gastrointestinal Disorders

Abnormal LFTs
Michele Ritter

Program for  Autoimmune Disease Intervention (PADI)

Latest 200 published articles:

1.    Clinical Efficacy of Beclomethasone Dipropionate in Korean Patients with Ulcerative Colitis Lee, Y.J., et al., Yonsei Med J, 2017. 58(1): p. 144-149.
2.    Study on the physicochemical properties and anti-inflammatory effects of paeonol in rats with TNBS-induced ulcerative colitis Zong, S.Y., et al., Int Immunopharmacol, 2016. 42: p. 32-38.
3.    Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal Anastomosis Zittan, E., et al., Inflamm Bowel Dis, 2016. 22(10): p. 2442-7.
4.    Ileal pouch-anal anastomosis for ulcerative colitis: a Canadian institution's experience Zittan, E., et al., Int J Colorectal Dis, 2016.
5.    Cytomegalovirus Reactivation in Ulcerative Colitis: What Can We Learn From Pathology? Zidar, N. and K. Tepes, Am J Gastroenterol, 2016. 111(11): p. 1658.
6.    The association between vitamin D receptor polymorphisms and serum 25-hydroxyvitamin D levels with ulcerative colitis in Chinese Han population Zheng, S.Z., et al., Clin Res Hepatol Gastroenterol, 2016.
7.    [Efficacy of Yunnan Baiyao as an adjuvant treatment for active ulcerative colitis: an open-label randomized controlled study] Zhao, W.Z., et al., Nan Fang Yi Ke Da Xue Xue Bao, 2016. 36(9): p. 1186-1191.
8.    Cell surface-anchored syndecan-1 ameliorates intestinal inflammation and neutrophil transmigration in ulcerative colitis Zhang, Y., et al., J Cell Mol Med, 2016.
9.    Skeletal muscle depletion correlates with disease activity in ulcerative colitis and is reversed after colectomy Zhang, T., et al., Clin Nutr, 2016.
10.    Mucosa-reparing and microbiota-balancing therapeutic effect of Bacillus subtilis alleviates dextrate sulfate sodium-induced ulcerative colitis in mice Zhang, H.L., et al., Exp Ther Med, 2016. 12(4): p. 2554-2562.
11.    Therapeutic effects of triptolide via the inhibition of IL-1beta expression in a mouse model of ulcerative colitis Zhang, H., et al., Exp Ther Med, 2016. 12(3): p. 1279-1286.
12.    Diagnostic evaluation of appendiceal orifice inflammation in ulcerative colitis Zhan, D.Q., et al., Turk J Gastroenterol, 2016. 27(5): p. 444-449.
13.    Budesonide foam for mild to moderate distal ulcerative colitis: a systematic review and meta-analysis Zeng, J., L. Lv, and Z.C. Mei, J Gastroenterol Hepatol, 2016.
14.    De novo Crohn's Disease after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis and Inflammatory Bowel Disease Unclassified: Long-Term Follow-Up of a Prospective Inflammatory Bowel Disease Registry Zaghiyan, K., et al., Am Surg, 2016. 82(10): p. 977-981.
15.    Simultaneous determination of anemoside B4, p., berberine, palmatine, obakunone, esculin, esculetin in rat plasma by UPLC-ESI-MS/MS and its application to a comparative pharmacokinetic study in normal and ulcerative colitis rats Yang, L., et al., J Pharm Biomed Anal, 2016. 134: p. 43-52.
16.    CBLB502 administration protects gut mucosal tissue in ulcerative colitis by inhibiting inflammation Xu, Y., et al., Ann Transl Med, 2016. 4(16): p. 301.
17.    Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis Xu, J., et al., Acta Biomater, 2016.
18.    Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, o.-l., pragmatic randomised trial Williams, J. G., et al., Lancet Gastroenterol Hepatol, 2016. 1(1): p. 15-24.
19.    The Impact of Biological Interventions for Ulcerative Colitis on Health-Related Quality of Life Whitehead, L., Am J Nurs, 2016. 116(11): p. 21.
20.    Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora Wei, Y., et al., J Transl Med, 2016. 16(1): p. 255.
21.    Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer Watanabe, T., et al., Gastroenterology, 2016. 151(6): p. 1122-1130.
22.    Antiviral Treatment for Colonic Cytomegalovirus Infection in Ulcerative Colitis Patients Significantly Improved Their Surgery Free Survival Wang, Y., et al., J Clin Gastroenterol, 2016.
23.    Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis Wang, Q.S., et al., Int J Pharm, 2016. 515(1-2): p. 176-185.
24.    Carbohydrate and protein intake and risk of ulcerative colitis: Systematic review and dose-response meta-analysis of epidemiological studies Wang, F., et al., Clin Nutr, 2016.
25.    Systematic Review with Network Meta-Analysis: Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative Colitis Vickers, A.D., et al., PLoS One, 2016. 11(10): p. e0165435.
26.    Predictors of tissue healing in ulcerative colitis patients treated with anti-TNF Viazis, N., et al., Dig Liver Dis, 2016.
27.    Long-term Follow-up After Ileorectal Anastomosis for Ulcerative Colitis: A GETAID/GETAID Chirurgie Multicenter Retrospective Cohort of 343 Patients Uzzan, M., et al., Ann Surg, 2016.
28.    Pouchitis in Pediatric Ulcerative Colitis Patients After Ileal Pouch Anal Anastomosis Uchida, K., et al., J Pediatr Gastroenterol Nutr, 2016. 63(6): p. e211.
29.    Effectiveness of golimumab in inducing remission and clinical response in outpatient ulcerative colitis Tursi, A., et al., Clin Res Hepatol Gastroenterol, 2016. 40(5): p. e61-e63.
30.    Concomitant hidradenitis suppurativa and pyostomatitis vegetans in silent ulcerative colitis successfully treated with golimumab Tursi, A., Dig Liver Dis, 2016.
31.    Once- Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial Turner, D., et al., J Crohns Colitis, 2016.
32.    CDX2 expression induced by leukocytapheresis might be associated with mucosal healing in ulcerative colitis Tsuchiya, K., et al., J Gastroenterol Hepatol, 2016.
33.    A review of the cost-effectiveness of vedolizumab for treating moderate- to severely active ulcerative colitis Tsai, H.H. and C. Black, Expert Rev Pharmacoecon Outcomes Res, 2016. 16(6): p. 679-683.
34.    An uncommon presentation of ulcerative colitis Tp, R., et al., J Assoc Physicians India, 2016. 64(1): p. 106.
35.    Could Total Colectomy with Ileorectal Anastomosis Be an Alternative to Total Proctocolectomy with Ileal Pouch-Anal Anastomosis in Selected Ulcerative Colitis Patients? Tonelli, F., C. Di Martino, and F. Giudici, Gastroenterol Res Pract, 2016. 2016: p. 5832743.
36.    Cytokine levels after consumption of a Medicinal Agaricus blazei Murill-based Mushroom Extract, A., in Patients with Crohn's disease and Ulcerative Colitis in a Randomized Single-Blinded Placebo Controlled Study Therkelsen, S. P., et al., Scand J Immunol, 2016.
37.    A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients Takeshita, K., et al., Inflamm Bowel Dis, 2016. 22(12): p. 2802-2810.
38.    Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis Szeto, M.C., et al., Case Reports Immunol, 2016. 2016: p. 7562123.
39.    Endoscopic morphological features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement Sugimoto, S., et al., Gastroenterol Res Pract, 2016.
40.    Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium Study Sticlaru, L., et al., Dis Markers, 2016. 22(10): p. 2311-6.
41.    Restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis: A narrative review Sofo, L., et al., World J Gastrointest Surg, 2016. 8(8): p. 556-63.
42.    MANAGEMENT OF ACUTE SEVERE ULCERATIVE COLITIS: A CLINICAL UPDATE Sobrado, C.W. and L.F. Sobrado, Arq Bras Cir Dig, 2016. 29(3): p. 201-205.
43.    Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, M.F.T.S., R., et al., Clin Gastroenterol Hepatol, 2016.
44.    Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis Shinzaki, S., et al., J Crohns Colitis, 2016.
45.    Hand-assisted laparoscopic restorative proctocolectomy for ulcerative colitis Shimada, N., et al., World J Gastrointest Surg, 2016. 8(8): p. 578-82.
46.    Oral administration of Lentinus edodes beta-glucans ameliorates DSS-induced ulcerative colitis in mice via MAPK-Elk-1 and MAPK-PPARgamma pathways Shi, L., et al., Food Funct, 2016. 7(11): p. 4614-4627.
47.    The Evaluation of Postoperative Patients with Ulcerative Colitis Shen, B., Mediators Inflamm, 2016. 26(4): p. 669-77.
48.    Successful colonoscopic fecal microbiota transplantation for active ulcerative colitis: First report from India Seth, A.K., et al., Indian J Gastroenterol, 2016. 35(5): p. 393-395.
49.    Central Retinal Vein Occlusion Associated with Ulcerative Colitis Seo, Y., et al., Optom Vis Sci, 2016. 93(12): p. 1567-1570.
50.    Increased Proliferation of the Ileal Epithelium as a Remote Effect of Ulcerative Colitis Sedghi, S., et al., Inflamm Bowel Dis, 2016. 22(10): p. 2369-81.
51.    Ozanimod Treatment for Ulcerative Colitis Sandborn, W.J. and B.G. Feagan, N Engl J Med, 2016. 375(8): p. e17.
52.    An Unusual Case of Intestinal Obstruction in Ulcerative Colitis Sanchez-Guillen, L., F. Blanco-Antona, and M. Millan-Scheiding, Gastroenterology, 2016. 151(6): p. e12-e14.
53.    Resveratrol Supplementation and Oxidative/Anti-Oxidative Status in Patients with Ulcerative Colitis: A Randomized, D.-B., Placebo-controlled Pilot Study Samsamikor, M., et al., Arch Med Res, 2016. 47(4): p. 304-9.
54.    Ferulic acid ameliorates TNBS-induced ulcerative colitis through modulation of cytokines, o.s., iNOs, COX-2, and apoptosis in laboratory rats Sadar, S. S., N.S. Vyawahare, and S.L. Bodhankar, Excli j, 2016. 15: p. 482-499.
55.    Yellow fever vaccination during treatment with infliximab in a patient with ulcerative colitis: A case report Ruddel, J., et al., Z Gastroenterol, 2016. 54(9): p. 1081-4.
56.    Protective Effect of Amphipterygium adstringens Extract on Dextran Sulphate Sodium-Induced Ulcerative Colitis in Mice Rodriguez-Canales, M., et al., 2016. 2016: p. 8543561.
57.    Development of an indirect immunofluorescence based assay for diagnosis of ulcerative colitis in Indian population Rodrigues, A.V., et al., Immunol Lett, 2016. 181: p. 20-25.
58.    Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis Rivas, M.A., et al., Nat Commun, 2016. 7: p. 12869.
59.    [Cutaneous involvement in chronic inflammatory bowel disease : Crohn's disease and ulcerative colitis] Richter, L. and K. Rappersberger, Hautarzt, 2016.
60.    Reens, J., M.o.i.a.p.w.a.u.c.I.t.a.r.w.t.d.a.t.u.o.g.t.y.b.A.b.r.o.t.l., et al., PLoS One, 2016. 167(4): p. 121-3.
61.    IBD: A role for GATA3 in ulcerative colitis Ray, K., Nat Rev Gastroenterol Hepatol, 2016. 13(11): p. 624.
62.    Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies Randall, K. and N. Henderson, 2016. 11(9): p. e0162076.
63.    Involvement of PPARgamma in the protective action of tropisetron in an experimental model of ulcerative colitis Rahimian, R., et al., Immunopharmacol Immunotoxicol, 2016: p. 1-9.
64.    Anti TNF-alpha therapy for ulcerative colitis: current status and prospects for the future Pugliese, D., et al., Expert Rev Clin Immunol, 2016: p. 1-11.
65.    Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study Prieux-Klotz, C., et al., Dig Dis Sci, 2016.
66.    Expression Profile of p53 and p21 in Large Bowel Mucosa as Biomarkers of Inflammatory-Related Carcinogenesis in Ulcerative Colitis Popp, C., et al., 2016. 2016: p. 3625279.
67.    The dual role of Escherichia coli in the course of ulcerative colitis Pilarczyk-Zurek, M., et al., BMC Gastroenterol, 2016. 16(1): p. 128.
68.    The influence of lipoic acid on caveolin-1-regulated antioxidative enzymes in the mouse model of acute ulcerative colitis Piechota-Polanczyk, A., et al., Biomed Pharmacother, 2016. 84: p. 470-475.
69.    Concomitant herpes simplex virus colitis and hepatitis in a man with ulcerative colitis: Case report and review of the literature Phadke, V.K., et al., Medicine (Baltimore), 2016. 95(42): p. e5082.
70.    Implementing the Concept of Continuous Clinical Response Into Clinical Practice for Ulcerative Colitis Peyrin-Biroulet, L., et al., Clin Gastroenterol Hepatol, 2016.
71.    Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis Peyrin-Biroulet, L., et al., Aliment Pharmacol Ther, 2016. 44(8): p. 807-16.
72.    Ethnic variations in ulcerative colitis: Experience of an international hospital in Thailand Permpoon, V., K. Pongpirul, and S. Anuras, World J Gastrointest Pharmacol Ther, 2016. 7(3): p. 428-33.
73.    Role of Histologic Inflammation in the Natural History of Ulcerative Colitis Patil, D.T., A.C. Moss, and R.D. Odze, Gastrointest Endosc Clin N Am, 2016. 26(4): p. 629-40.
74.    Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis Park, S., et al., Am J Gastroenterol, 2016.
75.    Direct and Indirect Effects of Tofacitinib on Treatment Satisfaction in Patients with Ulcerative Colitis Panes, J., et al., J Crohns Colitis, 2016. 10(11): p. 1310-1315.
76.    The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study Palumbo, V.D., et al., Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2016. 160(3): p. 372-7.
77.    An uncommon presentation of ulcerative colitis P, R.T., et al., J Assoc Physicians India, 2016. 64(1): p. 85.
78.    A Case of Ulcerative Colitis Following Acute Hepatitis Induced by Epstein-Barr Virus Infection Oh, S.H., et al., Korean J Gastroenterol, 2016. 68(2): p. 104-8.
79.    Controversies in J Pouch Surgery for Ulcerative Colitis: A Focus on Handsewn Versus Stapled Anastomosis Nobel, T., S. Khaitov, and A.J. Greenstein, Inflamm Bowel Dis, 2016. 22(9): p. 2302-9.
80.    Clinical usefulness of narrow band imaging magnifying colonoscopy for assessing ulcerative colitis-associated cancer/dysplasia Nishiyama, S., et al., Endosc Int Open, 2016. 4(11): p. E1183-e1187.
81.    Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis Nishida, A., et al., J Gastroenterol, 2016.
82.    Coordinated Hospital-Home Fecal Microbiota Transplantation via Percutaneous Endoscopic Cecostomy for Recurrent Steroid-Dependent Ulcerative Colitis Ni, X., et al., Gut Liver, 2016. 10(6): p. 975-980.
83.    Recent trends and future directions for the medical treatment of ulcerative colitis Naganuma, M., et al., Clin J Gastroenterol, 2016. 9(6): p. 329-336.
84.    Ozanimod Treatment for Ulcerative Colitis Mutneja, H.R., S. Arora, and A. Vij, N Engl J Med, 2016. 375(8): p. e17.
85.    Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications Muthas, D., et al., Scand J Gastroenterol, 2016: p. 1-11.
86.    Impairment of Small Intestinal Function in Ulcerative Colitis: Role of Enteric Innervation Mourad, F.H., K.A. Barada, and N.E. Saade, J Crohns Colitis, 2016.
87.    Comparison of Cytokine and Efflux Transporter Expression in Pediatric vs. Adult Onset Ulcerative Colitis Mlakar, A.S., et al., J Pediatr Gastroenterol Nutr, 2016.
88.    Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis Mirsepasi-Lauridsen, H.C., et al., Sci Rep, 2016. 6: p. 31152.
89.    Simultaneous Presentation of Idiopathic Duct-Centric Pancreatitis and Ulcerative Colitis Marques, S., et al., ACG Case Rep J, 2016. 3(4): p. e131.
90.    BBI-D-16-00318R1, I.u.c.a.r.d.C.o.F.a.a.h.F.b.a.e.c.b.a.m.e.a.s.i., Brain Behav Immun, 2016.
91.    Disease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis Patients Mar, J.S., et al., MBio, 2016. 7(4).
92.    Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis Mao, E.J., et al., Aliment Pharmacol Ther, 2016.
93.    Oral manifestations of gastrointestinal diseases in children. Part 3: Ulcerative colitis and gastro-oesophageal reflux disease Mantegazza, C., F. Angiero, and G.V. Zuccotti, Eur J Paediatr Dent, 2016. 17(3): p. 248-250.
94.    Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis Manguso, F., et al., PLoS One, 2016. 11(11): p. e0166455.
95.    Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study Magro, F., et al., J Crohns Colitis, 2016.
96.    Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls Lundgren, D., et al., BMC Gastroenterol, 2016. 16(1): p. 139.
97.    Ileal pouch-anal anastomosis 20 years later: is it still a good surgical option for patients with ulcerative colitis? Lorenzo, G., et al., Int J Colorectal Dis, 2016. 31(12): p. 1835-1843.
98.    Perceived Emotional and Psychological Impact of Ulcerative Colitis on Outpatients in Spain: UC-LIFE Survey Lopez-Sanroman, A., et al., Dig Dis Sci, 2016.
99.    Long-term Efficacy of Vedolizumab for Ulcerative Colitis Loftus, E.V., Jr., et al., J Crohns Colitis, 2016.
100.    Elderly Adults with Late-Onset Ulcerative Colitis Tend to Have Atypical, M.I.C.P.b.H.S.R.a.M.A.T.S.o.I.B.D.S.L., et al., J Am Geriatr Soc, 2016. 64(10): p. e95-e97.
101.    Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing Lin, J., et al., Microrna, 2016.
102.    Fecal microbiota in pouchitis and ulcerative colitis Li, K.Y., et al., World J Gastroenterol, 2016. 22(40): p. 8929-8939.
103.    Colonic biogeography in health and ulcerative colitis Lavelle, A., et al., Gut Microbes, 2016. 7(5): p. 435-42.
104.    A Case of Thiopurine-Induced Acute Myocarditis in a Patient with Ulcerative Colitis Latushko, A. and L.J. Ghazi, Dig Dis Sci, 2016. 61(12): p. 3633-3634.
105.    Stress, c.a.s.n.o.p.w.u.c.o.C.s.d.a.q.d.s.L., K., L. Loof, and K. Nordin, J Clin Nurs, 2016.
106.    Autophagy-related protein 7 level in patients with ulcerative colitis Lankarani, K.B., et al., Scand J Gastroenterol, 2016: p. 1.
107.    alphaEbeta7 integrin identifies subsets of pro-inflammatory colonic CD4+ T lymphocytes in ulcerative colitis Lamb, C.A., et al., J Crohns Colitis, 2016.
108.    Low prevalence of dysplastic polyps in patients with ulcerative colitis Laish, I., et al., Clin Res Hepatol Gastroenterol, 2016.
109.    Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China Lai, Y.M., et al., Gut Liver, 2016.
110.    Interleukin-10 is differentially expressed in the small intestine and the colon experiencing chronic inflammation and ulcerative colitis induced by dextran sodium sulfate in young pigs Lackeyram, D., et al., Physiol Res, 2016.
111.    Failure of Fecal Microbiota Transplantation in a Three-Year-Old Child with Severe Refractory Ulcerative Colitis Kumagai, H., et al., Pediatr Gastroenterol Hepatol Nutr, 2016. 19(3): p. 214-220.
112.    Midkine is up-regulated in both cancerous and inflamed bowel, r.l.n.m.i.c.c.a.c.a.o.u.c.K.-K., M., et al., Cytokine, 2016.
113.    Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma Kryczek, I., et al., Oncoimmunology, 2016. 5(8): p. e1105430.
114.    Fulminant ulcerative colitis complicated by treatment-refractory bacteremia Krease, M., et al., Proc (Bayl Univ Med Cent), 2016. 29(4): p. 407-408.
115.    Inflammatory Bowel Diseases (Crohn s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications Kostic, M., et al., Appl Health Econ Health Policy, 2016.
116.    Tacrolimus Therapy for Three Patients with Elderly-Onset Ulcerative Colitis: Report of Three Cases Kobayashi, R., S. Matsumoto, and Y. Yoshida, Case Rep Gastroenterol, 2016. 10(2): p. 392-398.
117.    [Long-term infliximab therapy for ulcerative colitis in real clinical practice] Knyazev, O.V., et al., Ter Arkh, 2016. 88(8): p. 46-52.
118.    Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis Kisiel, J.B., et al., Clin Gastroenterol Hepatol, 2016. 14(12): p. 1778-1787.e8.
119.    [Morphological changes in the colonic muscular layer and interstitial cells of Cajal in experimental acute ulcerative colitis] Kiryukhin, S.O. and O.V. Makarova, Arkh Patol, 2016. 78(5): p. 27-32.
120.    Can narrow-band imaging of Peyer's patches predict the recurrence of ulcerative colitis? Kim, Y.J., Intest Res, 2016. 14(4): p. 295-296.
121.    Treatment Targets in Ulcerative Colitis Khanna, R. and V. Jairath, Gastroenterology, 2016.
122.    Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study Khalili, H., et al., Am J Gastroenterol, 2016. 111(11): p. 1614-1620.
123.    Restoring Mucosal Barrier Function and Modifying Macrophage Phenotype with an Extracellular Matrix Hydrogel: Potential Therapy for Ulcerative Colitis Keane, T.J., et al., J Crohns Colitis, 2016.
124.    Spinal epidural abscess: a rare complication of ulcerative colitis after ileal pouch anal anastomosis Kawamura, M., et al., Surg Case Rep, 2016. 2(1): p. 128.
125.    An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis Kawalec, P. and A. Pilc, Arch Med Sci, 2016. 12(5): p. 1097-1109.
126.    Role of synbiotics in polysaccharide assisted colon targeted microspheres of Mesalamine for the treatment of ulcerative colitis Kaur, R., M. Gulati, and S.K. Singh, Int J Biol Macromol, 2016.
127.    Intestinal Intravascular Large B-cell Lymphoma Mimicking Ulcerative Colitis with Secondary Membranoproliferative Glomerulonephritis Kaneyuki, D., et al., Intern Med, 2016. 55(17): p. 2475-81.
128.    The Role of Syndrome Differentiation in the Clinical Efficacy of Punica Granatum on Patients with Ulcerative Colitis Kamali, M., et al., Iran J Med Sci, 2016. 41(3 Suppl): p. S15.
129.    IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being Jonefjall, B., et al., Inflamm Bowel Dis, 2016. 22(11): p. 2630-2640.
130.    Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm Johnsen, K.M., et al., Eur J Gastroenterol Hepatol, 2016.
131.    Review of Clinical Studies of the Treatment of Ulcerative Colitis Using Acupuncture and Moxibustion Ji, J., et al., 2016. 2016: p. 9248589.
132.    Regulatory effects of glycyrrhizae radix extract on DSS-induced ulcerative colitis Jeon, Y.D., et al., BMC Complement Altern Med, 2016. 16(1): p. 459.
133.    A Simplified Geboes Score for Ulcerative Colitis Jauregui-Amezaga, A., et al., J Crohns Colitis, 2016.
134.    Sphingosine-1-phosphate receptor: a novel therapeutic target in ulcerative colitis Izzo, R., M.M. Figliuzzi, and G. Monteleone, Expert Rev Clin Immunol, 2016. 12(11): p. 1137-1139.
135.    Outcome and functional prognosis of pelvic sepsis after ileal pouch-anal anastomosis in patients with ulcerative colitis Ide, S., et al., Surg Today, 2016.
136.    Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naive and non-naive patients Iborra, M., et al., J Gastroenterol, 2016.
137.    Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naive and non-naive patients Iborra, M., et al., J Gastroenterol, 2016.
138.    Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis Hu, J., et al., Exp Ther Med, 2016. 12(5): p. 2983-2989.
139.    Narrow-band imaging with magnifying endoscopy for Peyer's patches is useful in predicting the recurrence of remissive patients with ulcerative colitis Hiyama, S., et al., Intest Res, 2016. 14(4): p. 314-321.
140.    Acute severe ulcerative colitis: from pathophysiology to clinical management Hindryckx, P., V. Jairath, and G. D'Haens, Nat Rev Gastroenterol Hepatol, 2016. 13(11): p. 654-664.
141.    Pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: diagnosis, m., risk factors, and incidence Hata, K., et al., Dig Endosc, 2016.
142.    Prospective Evaluation of Terminal Ileitis in a Surveillance Population of Patients with Ulcerative Colitis Hamilton, M.J., et al., Inflamm Bowel Dis, 2016. 22(10): p. 2448-55.
143.    Long-term outcome after ileal pouch-anal anastomosis for ulcerative colitis Hahnloser, D. and J. Pemberton, ANZ J Surg, 2016. 86(10): p. 741-742.
144.    A cross-ethnic survey of CFB and SLC44A4, I.u.c.G.h., underscores their potential role in disease susceptibility Gupta, A., et al., Eur J Hum Genet, 2016.
145.    Autonomic nervous system function predicts the inflammatory response over three years in newly diagnosed ulcerative colitis patients Gunterberg, V., et al., Can J Gastroenterol Hepatol, 2016. 28(11): p. 1655-1662.
146.    Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis Gundersen, M.D., et al., Sci Rep, 2016. 6: p. 35403.
147.    Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis Guirgis, M., et al., J Crohns Colitis, 2016.
148.    [Quality of Life after colectomy due to ulcerative colitis] Gudlaugsdottir, K., E.B. Valsdottir, and T.B. Stefansson, Laeknabladid, 2016. 102(11): p. 482-489.
149.    A National Survey of the Prevalence and Impact of Cytomegalovirus Infection Among Hospitalized Patients With Ulcerative Colitis Grossberg, L.B., et al., J Clin Gastroenterol, 2016.
150.    Lycopene, L.a.Z.M.R.F.B., Mucus and Pus but not Abdominal Pain in Individuals with Ulcerative Colitis Glabska, D., et al., Nutrients, 2016. 8(10).
151.    Epidemiological and clinical aspects of ulcerative colitis in west of Iran: a cross sectional study Ghanadi, K., J. Valizadeh, and A. Hasanvand, Springerplus, 2016. 5(1): p. 1588.
152.    Molecular topology: a strategy to identify novel compounds against ulcerative colitis Galvez-Llompart, M., et al., Mol Divers, 2016.
153.    Assessment of the Family History of Patients With Ulcerative Colitis at a Single Center in Japan Fujii, T., et al., J Pediatr Gastroenterol Nutr, 2016. 63(5): p. 512-515.
154.    Accuracies of fecal calprotectin, l., M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitis Frin, A. C., et al., Dig Liver Dis, 2016.
155.    Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD "AGED study" Fries, W., et al., Dig Liver Dis, 2016.
156.    Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease marker Fohlinger, M., et al., 2016. 14(1): p. 310.
157.    The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitis Fernandes, S.R., et al., Rev Esp Enferm Dig, 2016. 108(11): p. 697-702.
158.    Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, R.o.P.E.t.T.A.F., B. G., et al., Clin Gastroenterol Hepatol, 2016.
159.    Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial Feagan, B.G., et al., Aliment Pharmacol Ther, 2016.
160.    Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis Farkas, K., et al., J Crohns Colitis, 2016. 10(11): p. 1273-1278.
161.    Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis Espaillat, M.P., R.R. Kew, and L.M. Obeid, Adv Biol Regul, 2016.
162.    Randomized, d.-b., placebo-controlled trial of CCR9-targeted leukapheresis treatment of ulcerative colitis patients Eberhardson, M., et al., J Crohns Colitis, 2016.
163.    Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers Duranti, S., et al., FEMS Microbiol Ecol, 2016. 92(12).
164.    Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis Dotti, I., et al., Gut, 2016.
165.    Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, M.P.I.T.D., I., et al., Dig Dis Sci, 2016. 61(11): p. 3246-3254.
166.    Integrative Network-based Analysis of Colonic Detoxification Gene Expression in Ulcerative Colitis According to Smoking Status Ding, Y.P., et al., J Crohns Colitis, 2016.
167.    Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution Diaz-Jimenez, D., et al., BMC Gastroenterol, 2016. 16: p. 103.
168.    Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis D'Haens, G., Aliment Pharmacol Ther, 2016. 44(10): p. 1018-1029.
169.    Beneficial effect of Amorphophallus paeoniifolius tuber on experimental ulcerative colitis in rats Dey, Y.N., et al., Pharm Biol, 2016: p. 1-10.
170.    Outcome of acute severe ulcerative colitis in patients previously exposed to immunosuppressive therapy Deiana, S., et al., Dig Liver Dis, 2016.
171.    Male-specific association between MT-ND4 11719 A/G polymorphism and ulcerative colitis: a mitochondria-wide genetic association study Dankowski, T., et al., BMC Gastroenterol, 2016. 16(1): p. 118.
172.    Clinical presentation and treatment strategies for ulcerative colitis: A retrospective study of 247 inpatients Dai, Y.C., et al., Chin J Integr Med, 2016. 22(11): p. 811-816.
173.    Letter: anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 for ulcerative colitis Cui, D.J., H. Chen, and M. Hu, Aliment Pharmacol Ther, 2016. 44(7): p. 767.
174.    Blastocystis in ulcerative colitis patients: Genetic diversity and analysis of laboratory findings Coskun, A., et al., Asian Pac J Trop Med, 2016. 9(9): p. 916-9.
175.    The 100 classic papers in ulcerative colitis: a bibliometric analysis Connelly, T.M., et al., Expert Rev Gastroenterol Hepatol, 2016: p. 1-9.
176.    Effects of concomitant immunomodulators on the pharmacokinetics, e.a.s.o.a.i.p.w.C.s.d.o.u.c.w.h.f.c.t.C., J. F., et al., Aliment Pharmacol Ther, 2016.
177.    Effect of Long Noncoding RNA H19 Overexpression on Intestinal Barrier Function and Its Potential Role in the Pathogenesis of Ulcerative Colitis Chen, S.W., et al., Inflamm Bowel Dis, 2016. 22(11): p. 2582-2592.
178.    Protective effects of Huangqin Decoction against ulcerative colitis and associated cancer in mice Chen, G., et al., Oncotarget, 2016.
179.    Prevalence of Colonic Diverticulosis in Patients Affected by Ulcerative Colitis: A Prospective Study Cassieri, C., et al., J Clin Gastroenterol, 2016. 50 Suppl 1: p. S33-5.
180.    Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, U.C.a.O.C., C., E.O. Petrof, and E. Allen-Vercoe, EBioMedicine, 2016.
181.    Investigation of IL23R, J., and STAT3 gene polymorphisms and gene-gene interactions in Crohn's disease and ulcerative colitis in a Turkish population Can, G., et al., Turk J Gastroenterol, 2016. 27(6): p. 525-536.
182.    Oral Vancomycin Therapy in a Child with Primary Sclerosing Cholangitis and Severe Ulcerative Colitis Buness, C., K.D. Lindor, and T. Miloh, Pediatr Gastroenterol Hepatol Nutr, 2016. 19(3): p. 210-213.
183.    Online Social Support for Participants of Crohn's and Ulcerative Colitis Groups Britt, R.K., Health Commun, 2016: p. 1-10.
184.    A low-cost method for chromoendoscopy for surveillance in ulcerative colitis Bopanna, S., S. Kedia, and V. Ahuja, Indian J Gastroenterol, 2016.
185.    Implementation of the French national consensus for the management of ulcerative colitis into clinical practice Bonnaud, G., et al., Dig Liver Dis, 2016.
186.    The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technology Bezzio, C., et al., Expert Rev Gastroenterol Hepatol, 2016: p. 1-9.
187.    MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease Phenotypes Ben-Shachar, S., et al., PLoS One, 2016. 11(8): p. e0159956.
188.    Correction: MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease Phenotypes Ben-Shachar, S., et al., PLoS One, 2016. 11(10): p. e0165220.
189.    Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis Beilman, C.L. and N.X. Thanh, 2016. 2016: p. 5315798.
190.    Perceived Risks Contra Benefits of Using Biosimilar Drugs in Ulcerative Colitis: Discrete Choice Experiment among Gastroenterologists Baji, P., et al., Value Health Reg Issues, 2016. 10: p. 85-90.
191.    Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis Atreya, R., et al., J Crohns Colitis, 2016. 10(11): p. 1294-1302.
192.    Vascular High Ligation and Embryological Dissection in Laparoscopic Restorative Proctocolectomy for Ulcerative Colitis Atasoy, D., et al., J Laparoendosc Adv Surg Tech A, 2016.
193.    The effect of CYP3A5 genetic polymorphisms on adverse events in patients with ulcerative colitis treated with tacrolimus Asada, A., et al., Dig Liver Dis, 2016.
194.    Ulcerative Colitis in Colonic Interposition for Esophageal Atresia Arshad, H.M., E. Tetangco, and I. Elkhatib, ACG Case Rep J, 2016. 3(4): p. e149.
195.    Biologics for the treatment of pyoderma gangrenosum in ulcerative colitis Arivarasan, K., et al., Intest Res, 2016. 14(4): p. 365-368.
196.    The Ulcerative Colitis Endoscopic Index of Severity is Useful to Predict Medium- to Long-Term Prognosis in Ulcerative Colitis Patients with Clinical Remission Arai, M., et al., J Crohns Colitis, 2016. 10(11): p. 1303-1309.
197.    [Thrombotic skin gangrene: A rare extra-intestinal manifestation of ulcerative colitis] Aounallah, A., et al., Ann Dermatol Venereol, 2016.
198.    Update on medical and surgical options for patients with acute severe ulcerative colitis: What is new? Andrew, R.E. and E. Messaris, World J Gastrointest Surg, 2016. 8(9): p. 598-605.
199.    A Rare Case of Colonic Leiomyosarcoma in Association with Ulcerative Colitis Akutsu, D., et al., Intern Med, 2016. 55(19): p. 2799-2803.
200.    Attachment and perceived stress in patients with ulcerative colitis, a.c.-c.s.A., A., et al., J Psychiatr Ment Health Nurs, 2016. 23(9-10): p. 561-567.


20 July 2015

Acute Liver Failure Ppts and 485 ltest published articles

Acute Liver Failure

Acute Liver Failure
Milton G. Mutchnick, M.D.

Acute Liver Failure

Fulminant Hepatic Failure
Christine Williams, MD

Management of Patients with Hepatic/Biliary Dysfunction
Marjorie Miller MA RN Minor Edit by Timothy Frank MS RN

Fulminant Hepatic Failure &
Liver Transplantation

Liver Disease
Thomas C Sodeman MD FACP

Bio-Artificial Liver (Extracorporeal temporary liver support devices)
Alan Golde Jr.

Liver transplant evaluation for cirrhosis due to Wilson’s disease
Richa Shukla

Tissue Engineering of the Liver
Cara Nunez


485 Published articles on Acute Liver Failure


01 March 2014

Zollinger–Ellison syndrome ppts and latest 100 publications

Zollinger–Ellison syndrome

Zollinger–Ellison Syndrome (ZES) is caused by a non–beta islet cell, gastrin-secreting tumor of the pancreas that stimulates the acid-secreting cells of the stomach to maximal activity, with consequent gastrointestinal mucosal ulceration.

Rajeev Kumar, MD

Pub-Style Medicine Trivia

Gastric Acid Modifiers or Gastric Acid Suppression (GAS)
Frank F. Vincenzi

Drugs Affecting the Gastrointestinal System and Nutrition
Jan Bazner-Chandler

Medical Nutrition Therapy for Gastrointestinal Tract Disorders

Ulcer Disease Update
Hagop S. Mekhjian, MD

Cytotoxic Chemotherapy, Somatostatin Analogs and PRRT in NEC: Why, When and How to give?
Manisha H. Shah, M.D.

Drugs Acting on the GI Tract: Peptic Ulcer and Motility & Secretions

Disorders of Gastrointestinal

Celiac Disease
Lianne Beck, MD

Diseases of the Gastrointestinal Tract

Small Intestinal Disorders/Malabsorption
Ralph Giannella, M.D.

Gastrointestinal Drugs
Patrick T. Ronaldson, Ph.D.

GI Disorders

Latest 100 Published articles of Zollinger–Ellison syndrome


02 December 2013

Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis
Primary sclerosing cholangitis is a disease of the bile ducts that causes inflammation and subsequent obstruction of bile ducts both at an intrahepatic and extrahepatic level.

Primary Sclerosing Cholangitis
Nirav Dhruva

Normal Liver

Ultrasound and MRI -
Case Report

Approach to the Jaundiced Patient - Internal Medicine Survivor Series

Cholestatic Liver Diseases
Rebecca W. Van Dyke, MD

Liver Diseases

Biliary diseases

Clinical Approach to Neonatal Jaundice
Dr. Siddeeg Addow

Tad Kim, M.D.
Connie Lee, M.D.

Godwin Tse


Liver Seminar for 
Health Plan Case Managers

Hepatitis A

Ashley Anderton, RN, BSN

Medical and Surgical Approach to Biliary and Gallbladder Disease
Norman H. Gilinsky, M.D., FACP, FACG

Clinicopathological Conference

The Yellow Man - Betsy Trowbridge
Case Presentation

Autoimmune Hepatitis
Thomas W. Faust, M.D.,M.B.E.

Liver Function Tests
Steve Bradley

Diseases of the Liver & Biliary Tract

Massive Hepatic Necrosis

Hilary Sanfey, MD

An Approach to Abnormal LFTs
Robert C. Lowe, M.D.


Medical Nutrition Therapy for Liver, Biliary System, and Exocrine Pancreas Disorders

Liver transplant patients & rehabilitation concerns
Jen Hokanson PTA, Trish Beck PT

Radiographic Imaging in Inflammatory Bowel Disease
Ed Barnes, MIV

Liver Disease
Thomas C Sodeman MD FACP

Hyperbilirubinemia in Term Neonates
Tanya Oberoi Pandya D.O., M.B.A. & Vishaan Pandya (Master’s In Colic, PhD in Poopology)

Pathology of the Gastrointestinal Tract

Assessment and Management of Patients With Hepatic Disorders
Miss Iman Shaweesh

Latest 300 Published articles on Primary Sclerosing Cholangitis


01 June 2013

Elevated serum alanine aminotransferase PPTs

Liver Enzymes, Viral Hepaitits, Autoimmune Hepatitis
Kimiko Suzue MD, Ph.D.

Laboratory Assessment a Method of Monitoring Liver, Coagulation, & Endocrine

Gallstones and Its Complications

Abnormal Liver enzymes and/or LFTs:  work-up and diagnosis What you need to know

Update on HBV and HCV
Robert G Gish MD

Amino Acid Catabolism Disposal of Nitrogen and Carbon Skeletons

Liver Tests:  Use and Interpretation
Rebecca W. Van Dyke, MD 

Thrombopoietin Receptor Agonists in Immune Thrombocytopenia
Kristen Sanfilippo M.D.

Medical Nutrition Therapy for Liver, Biliary System, and Exocrine Pancreas Disorders

Laboratory Science for Non-Laboratory Personnel
Michelle Draper, MBA, MT(ASCP)

Interventions for Clients with Gastrointestinal Problems

Evaluation of abnormal liver tests
Fariba  Javadi MD

Amino Acid Catabolism

Hepatic and GI Systems
Dennis Stevens CRNA, MSN, ARNP

Hepatitus Viruses - Case Studies
Maryam Afifi, Osy Ndubaku, Lani Kwon

Elevated Liver Enzymes and Weight Loss 
Nick Siebers, M.D.

Clinical Laboratory Testing – Basic Clinical Chemistry
Cecile Sanders, M.Ed., MT(ASCP), CLS (NCA)

Stressors of the Gallbladder, Pancreas And Liver

Abnormal LFTs
Michele Ritter

Hepatology ABIM Review


27 January 2013

Percutaneous transhepatic cholangiography

Percutaneous transhepatic cholangiography
Gallstone Disease
Tad Kim, M.D., Connie Lee, M.D.

Catheter-based Suture-free Hepaticojejunostomy
John Seal MD

Management of Patients with Hepatic/Biliary Dysfunction

Management of Patients with Hepatic/Biliary Dysfunction
Marjorie A. Miller, RN, MA, Timothy Frank MS RN

Management of Patients with Hepatic/Biliary Dysfunction
Marjorie Miller MA RN Minor Edit by Timothy Frank MS RN

Disorders of the Biliary Tract

DOM Morning Report: Cholangitis

Case Study

Gastroenterology and Hepatology In-service Review Series

The Digestive System Gastrointestinal Tract

Care of the Client with Disorders of the Gallbladder

Medical and Surgical Approach to Biliary and Gallbladder Disease
Norman H. Gilinsky, M.D., FACP, FACG

Gastrointestinal System Assessment Techniques

Godwin Tse

Biliary Imaging
Ian Scharrer, MIV

Assessment of the Gastrointestinal System

Stressors of the Gastrointestinal System

15 Published articles of Percutaneous transhepatic cholangiography


30 October 2012

Abdominal paracentesis

Abdominal paracentesis is a surgical puncture of the abdominal cavity for the removal of fluid for diagnosis or treatment. 


Diagnostic Tests
Shurouq Qadose

Body Fluids
Deborah Goldstein

Geetha B. Thippeswamy, MD

Abdominal Trauma
Cheryl Pirozzi, MD

Procedurepalooza 2010
Jason Poston

Stressors of the Gallbladder, Pancreas And Liver

Intra-Abdominal Hypertension (IAH) & Abdominal Compartment Syndrome (ACS)

Intra-Abdominal Hypertension (IAH) Abdominal Compartment Syndrome (ACS)
By: Tim Wolfe, MD

Dr. David Cao

Therapy of Anaerobic Infections
Douglas Black, Pharm.D

Liver Dysfunction and GI Bleed Lecture 
Rose Bianchi, RN, DNSc.

79 Published articles on Abdominal paracentesis


27 September 2012

Meckel's diverticulum

Histology and Development of the Digestive System

Digestive System

Gastrointestinal Imaging
Dr. F. Neuffer

Abdominal Pain in The Pediatric Patient
Tim Weiner, M.D.

Bowel Obstruction
Timothy M. Farrell

Finding Sources of Obscure Lower GI Bleeding
William Kwan

Approach to Acute Abdominal Pain
Richard W. Stair, MD

Pregnancy: 1st and 2nd Trimesters

Pediatric Hematology Board Review
Lakshmi Venkateswaran MD

Case Report
Vincent Yang , M.D.

Gastrointestinal Bleeding
David A. Gremse, MD, FAAP, FACG

UGI Bleed
Obie M. Powell, M.D., Joseph A. Iocono, M.D.

Vomiting, Diarrhea & Constipation
Mark J. Koruda, MD

262 free full text published articles on Meckel's diverticulum


12 July 2012

Gastroenterology and Hepatology

Gastroenterology-Hepatology  Grand Rounds

GI & Liver Disease in Pregnancy
C. Brock Miller, MD

Gastroenterology  and Hepatology
In-service  Review Series

The hepatorenal syndrome

The  perioperative management  of the patient with Crohn’s Disease.
David  G. Binion, M.D.

Serological  Markers in IBD
Raymond  Cross, M.D.

Laryngeal  Cancer
Anh  Q. Truong

Gastrointestinal  Endoscopic Procedures and Antibiotic Prophylaxis
Patrick  Pfau, M.D.

Update  on Colon Cancer Screening  and Prevention
Patrick  R. Pfau, M.D.,

Approach to Upper Gastrointestinal Bleeding
Ryan D. Madanick, MD

Hepatic  Complications of IBD
Preeti  A. Reshamwala, MD

Acute GI Bleed

Microscopic Colitis
James Hawk MD


28 June 2012


Alterations in Elimination

Gastrointestinal reflux disease
Brannon Hyde, MD

Stephen J. Goldberg, M. D.

Dietary Management 
Prof. Morsi Arab

Fiber-Modified Diets for Lower GI Tract Disorders

Bowel and Urine Elimination

Basic Human Needs Bowel Elimination

Constipation Etiology

Prebiotics, Probiotics, & Antibiotics: Controversies in the Treatment of IBS
Brian E. Lacy, Ph.D., M.D.

Common Childhood Diseases

Gastrointestinal & Hepatic-Biliary Systems

Medical Nutrition Therapy for Lower Gastrointestinal Tract Disorders

Celiac Disease
Lianne Beck, MD

Bowel Elimination

Board Review: Inflammatory Bowel Diseases

Bowel Elimination
K. Burger

Abdominal Pain

112 Published articles list


21 June 2012

Abdominal Distention

Acute Abdominal Pain Lower GI Problems
Acute Abdominal Pain Lower GI Problems.ppt


Abdominal Pain
Abdominal Pain.ppt

Abdominal Pain
Abdominal Pain.ppt

Approach to Abdominal Pain
Mike Heavey
Approach to Abdominal Pain.PPT

Abdominal distention
Abdominal distention.ppt

Abdomen Assessment
D. Tanner, RN, MSN
Abdomen Assessment.ppt

Management of Patients with Pancreatic Disease
Management of Patients with Pancreatic Disease.ppt

Management of Patients With Intestinal and Rectal Disorders
Miss: Iman Shaweesh
Management of Patients With Intestinal and Rectal Disorders.ppt

Small Bowel Obstruction
Phillip R. Mason
Small Bowel Obstruction.ppt

GI Emergencies
Curry Bordelon, PNP-AC, MBA
GI Emergencies.ppt

Diseases of the Gastrointestinal Tract
Diseases of the Gastrointestinal Tract.ppt

Medical Emergencies
Medical Emergencies.ppt

Management of the Patient with Digestive Disorders
Marjorie A. Miller, RN, MA, Marjorie Miller MA RN, Timothy Frank MS RN
Management of the Patient with Digestive Disorders.ppt

Necrotizing Enterocolitis
Jennifer Kloesz, M.D.
Necrotizing Enterocolitis.ppt

Food Poisoning
Richard S. Weisman, Pharm.D.
Food Poisoning.ppt

Interventions for Clients with Noninflammatory Intestinal Disorders
Interventions for Clients with Noninflammatory Intestinal Disorders.ppt

106 Published articles on Abdominal Distention


01 June 2012

Hepatocellular Nodules

Hepatocellular Nodules
Michael Federle, MD

Essentials of Liver Imaging
Pablo R. Ros, MD, MPH, Valerie Vilgrain, MD, Koenraad J. Mortele, MD

Acute Responses to Hepatic Injury
Richard T Miller, GlaxoSmithKline
Acute Responses to Hepatic Injury.ppt

Toxic Effects of Hydrocarbons and Alcohols
Toxic Effects of Hydrocarbons and Alcohols.ppt

HIV Associated Malignancies
Amanda Peppercorn, M.D.

Hepatic Masses 
Sudha Kodali, M.D
Hepatic Masses.ppt

Liver Cirrhosis
K. Dionne Posey, MD, MPH
Liver Cirrhosis.ppt

Gastroenterology and Hepatology
Gastroenterology and Hepatology.ppt

Imaging in Clinical Practice
Alan Weissman, MD
Imaging in Clinical Practice.ppt

Cirrhosis Care Manual
Catherine Frenette, MD
Cirrhosis Care Manual.ppt

Hepatitis B Virus: Overview

Lung Metastasis
Erin Carney, MD, Srivatsan Raghavan, MSIV, Pedram Argani, MD

Adjuvant Therapy for Hepatocellular Carcinoma
Carl R. Schmidt, MD, MSCI
Adjuvant Therapy.ppt

Surveillance for Early Diagnosis of Hepatocellular Carcinoma
Narges Farahi, MD

Prognostic value of FDG-PET for early stage carcinomas
Boone Goodgame, MD
Prognostic value of FDG-PET.ppt

To bleed or not to bleed: adverse effects of anti-angiogenics
Boone Goodgame, M.D.
To bleed or not to bleed.ppt

Hepatocellular Carcinoma
Aaron Wagner
Hepatocellular Carcinoma.ppt

Benign liver masses - Basic workup
Benign liver masses.ppt

Approach to Elevated LFTs
Approach to Elevated LFTs.ppt

Occupational Health
Marco A. Muñiz, D.O., M.P.H
Occupational Health.ppt
Occupational Health2.ppt

Hepatocellular Carcinoma

Practical Management of a Liver Mass
David J. Reich, MD, FACS
Practical Management of a Liver Mass.ppt

Diseases of the Liver & Biliary Tract
Diseases of the Liver & Biliary Tract.ppt

Gastrointestinal System and Metabolism Block

Introduction to Radiation Health: Late Effects - Cancer
Dr. Niel Wald
Introduction to Radiation Health.ppt

Nuclear Medicine & Positron Emission Tomography
Richard S.Kuebler,M.D.,J.D.
Nuclear Medicine & Positron Emission Tomography.ppt

Liver Diseases
Liver Diseases.ppt

Hepatitis Viruses
Hepatitis Viruses.ppt

Osteopathic Abdominal Exam
37 published scholarly articles


15 April 2012

Celiac Sprue

Celiac Sprue also known as celiac disease, gluten-sensitive enteropathy, and gluten-induced enteropathy, is a condition that damages the lining of the small intestine and prevents it from absorbing parts of food that are important for staying healthy.

Celiac Sprue
Douglas J. Marlow, M. D.

Living a Gluten-free Lifestyle
Marisa Bunning, PhD, Mary Schroeder MS, RD
Living a Gluten-free Lifestyle.ppt

Celiac Disease

Celiac Disease: It’s Autoimmune not an Allergy
Analissa Drummond

Celiac Disease
Rozina Mithani
Celiac Disease.ppt

Celiac Disease

Dietary Intolerances - Celiac Intolerance
Celiac Intolerance.ppt

Celiac Disease Recent Prevalence of Celiac Disease
Celiac Disease.ppt

Nutritional Megaloblastic Anemias
Megaloblastic Anemias.ppt

Evaluation of Abnormal LFTs

Trace Elements
Reed A Berger MD

Diet and Health Guidelines for Food Intolerances
Janice Hermann, PhD, RD/LD
Food Intolerances .ppt


10 April 2012

Nonalcoholic Steatohepatitis

Nutrition Intervention in Nonalcoholic steatohepatitis (NASH)
Michelle Stessman, RD, LD

Nonalcoholic Fatty Liver Disease

Gastroenterology and Hepatology Board Review
Jeff Singerman

Update on HBV and HCV

Medical Nutrition Therapy for Liver, Biliary System, and Exocrine Pancreas Disorders

Non-Alcoholic Fatty Liver Disease(NAFLD) A new consequence of the obesity epidemic.
Fernando Zapata

Medical Nutrition Therapy for Liver, Biliary System, and Exocrine Pancreas Disorders
Exocrine Pancreas Disorders.ppt

Acute Liver Failure

Abnormal LFTs
Michele Ritter

Abnormal Liver enzymes and/or LFTs: work-up and diagnosis

Nonalcoholic Fatty Liver Disease
Stephanie H. Abrams, M.D.
Nonalcoholic Fatty Liver Disease.ppt

Diabetes Complications: Screening, Avoidance and Management
Eric Lind Johnson, M.D.
Diabetes Complications: Screening, Avoidance and Management.ppt

Liver Cirrhosis
Liver Cirrhosis.ppt



Achalasia is a disorder of the tube that carries food from the mouth to the stomach (esophagus), which affects the ability of the esophagus to move food toward the stomach.

Management of Patients With Oral and Esophageal Disorders
Miss Iman shaweesh
Oral and Esophageal Disorders.ppt

Reflux disease
Brannon Hyde, MD
Reflux disease.ppt

Diseases of the Gastrointestinal Tract
Diseases of the Gastrointestinal Tract.ppt

GI Tract Unknowns
GI Tract Unknowns.ppt

Upper Gastrointestinal Disorders
Upper Gastrointestinal Disorders.ppt

Signs and Symptoms of Gastrointestinal Disease
Gastrointestinal Disease.ppt

Achalasia/Chagas Disease
Kunwar Sohal
Chagas Disease.ppt

Achalasia: A Tough Problem to Swallow
Jeremy P. Parcells, M.D.

Swallowing Difficulty & Pain
Tim Farrell, MD, Tom Egan, MD
Swallowing Difficulty & Pain.ppt


02 April 2012

Fecal impaction

Bowel Elimination
Bowel Elimination.ppt

Alteration in elimination: Bowel disease
Alteration in elimination: Bowel disease.ppt

Constipation in the Older Patient: When the Going gets Tough
Karen Hall, M.D, Ph.D.

Bowel Obstruction
Timothy M. Farrell

Management of Patients with Intestinal and Rectal Disorders
Miss Iman Shaweesh

Bowel EliminationK. Burger, MSEd, MSN, RN, CNE

Gastrointestinal Pharmacology

Intestinal Elimination Disorders
Intestinal Elimination Disorders.ppt

Alterations in Elimination
Alterations in Elimination.ppt

Chronic Diarrhoea
Chronic Diarrhoea.ppt

Laparoscopic Appendectomy
By Rob West
Laparoscopic Appendectomy.ppt


30 March 2012


Dyspepsia known as upset stomach or indigestion, refers to a condition of impaired digestion.

Dyspepsia Evaluation and Treatment of a Common Ambulatory Topic
Stuart Cohen MD

Gastrointestinal & Genitourinary Drugs
Sara McElroy
Gastrointestinal & Genitourinary Drugs.ppt

Medical Nutrition Therapy for Gastrointestinal Tract Disorders
Therapy for Gastrointestinal Tract Disorders.ppt

Recurrent abdominal pain
Dr. Kanupriya Chaturvedi
Recurrent abdominal pain.ppt

Management of Gastric and Duodenal Disorders
Gastric and Duodenal Disorders.ppt

Gastrointestinal Disorders

Acid Peptic Disorders The Spotlight is On!
Charmaine Rochester, PharmD, CDE, CDM, BCPS
Acid Peptic Disorders.ppt

Helicobacter Pylori: When should you diagnose and treat?
Christopher M. Mathews, M.D.
Helicobacter Pylori.ppt

Physical Diagnosis Examining the GI System
Stephen J. Goldberg, M. D.


26 March 2012

Cholelithiasis - gallstone disease

Cholelithiasis is the medical term for gallstone disease


Cholecystitis & Cholelithiasis
by: Gari Glaser

Gallbladder Disorders
Gallbladder Disorders.ppt

Diseases of the Biliary Tract
Victor Politi, M.D., FACP
Diseases of the Biliary Tract.ppt

Gallstone Disease
Gallstone Disease.ppt

Hepatobillary & Genitourinary
Hepatobillary & Genitourinary.ppt

Gallstone Disease
Tad Kim
Gallstone Disease.ppt

Ayla Guarino

Hepatic System
Hepatic System.ppt

Focus on Disorders of the Biliary Tract
Focus on Disorders of the Biliary Tract.ppt

Gallbladder Removal Among Obese Pediatric Patients
Gilbert Boissonneault PhD
Gallbladder Removal Among Obese Pediatric Patients.ppt

Care of the Client with Disorders of the Gallbladder
Disorders of the Gallbladder .ppt

Management of Biliary Disorders
Management of Biliary Disorders.ppt

Gallstones and Its Complications
Gallstones and Its Complications.ppt

Intrahepatic Stones
Warko Karnadihardja
Intrahepatic Stones.ppt

All links posted here are collected from various websites. No video or powerpoint files are uploaded on this blog. If you are the original author and do not wish to display your content on this blog please Email me anandkumarreddy at gmail dot com I will remove it. The contents of this blog are meant for educational purpose and not for commercial use. If you use any content give due credit to the original author.

This site uses cookies from Google to deliver its services, to personalise ads and to analyse traffic. Information about your use of this site is shared with Google. By using this site, you agree to its use of cookies.

  © Blogger templates Newspaper III by 2008

Back to TOP